
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
SARS-CoV-2 Spike Furin Cleavage Site and S2′ Basic Residues Modulate the Entry Process in a Host Cell-Dependent Manner
Muriel Lavie, Jean Dubuisson, Sandrine Belouzard
Journal of Virology (2022) Vol. 96, Iss. 13
Open Access | Times Cited: 39
Muriel Lavie, Jean Dubuisson, Sandrine Belouzard
Journal of Virology (2022) Vol. 96, Iss. 13
Open Access | Times Cited: 39
Showing 1-25 of 39 citing articles:
Mutational dynamics of SARS-CoV-2: Impact on future COVID-19 vaccine strategies
Niloofar Faraji, Tahereh Zeinali, Farahnaz Joukar, et al.
Heliyon (2024) Vol. 10, Iss. 9, pp. e30208-e30208
Open Access | Times Cited: 14
Niloofar Faraji, Tahereh Zeinali, Farahnaz Joukar, et al.
Heliyon (2024) Vol. 10, Iss. 9, pp. e30208-e30208
Open Access | Times Cited: 14
Discovering natural products as potential inhibitors of SARS-CoV-2 spike proteins
Muhammad Alqaaf, Ahmad Kamal Nasution, Mohammad Bozlul Karim, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Muhammad Alqaaf, Ahmad Kamal Nasution, Mohammad Bozlul Karim, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Architects of infection: A structural overview of SARS-related coronavirus spike glycoproteins
Francesca R. Hills, Jemma L. Geoghegan, Mihnea Bostina
Virology (2025), pp. 110383-110383
Open Access | Times Cited: 1
Francesca R. Hills, Jemma L. Geoghegan, Mihnea Bostina
Virology (2025), pp. 110383-110383
Open Access | Times Cited: 1
SARS-CoV-2 variants: Impact on biological and clinical outcome
Shakuntala Mahilkar, Sachee Agrawal, Sakshi Chaudhary, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 26
Shakuntala Mahilkar, Sachee Agrawal, Sakshi Chaudhary, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 26
The effects of amino acid substitution of spike protein and genomic recombination on the evolution of SARS-CoV-2
Letian Fang, Jie Xu, Yue Zhao, et al.
Frontiers in Microbiology (2023) Vol. 14
Open Access | Times Cited: 15
Letian Fang, Jie Xu, Yue Zhao, et al.
Frontiers in Microbiology (2023) Vol. 14
Open Access | Times Cited: 15
Sequential glycosylations at the multibasic cleavage site of SARS-CoV-2 spike protein regulate viral activity
Shengjun Wang, Wei Ran, Lingyu Sun, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 5
Shengjun Wang, Wei Ran, Lingyu Sun, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 5
Mutations in S2 subunit of SARS-CoV-2 Omicron spike strongly influence its conformation, fusogenicity, and neutralization sensitivity
Sahil Kumar, Rathina Delipan, Debajyoti Chakraborty, et al.
Journal of Virology (2023) Vol. 97, Iss. 11
Open Access | Times Cited: 11
Sahil Kumar, Rathina Delipan, Debajyoti Chakraborty, et al.
Journal of Virology (2023) Vol. 97, Iss. 11
Open Access | Times Cited: 11
Therapeutic antibodies and alternative formats against SARS-CoV-2
Rahel R. Winiger, Laurent Perez
Antiviral Research (2024) Vol. 223, pp. 105820-105820
Open Access | Times Cited: 4
Rahel R. Winiger, Laurent Perez
Antiviral Research (2024) Vol. 223, pp. 105820-105820
Open Access | Times Cited: 4
Towards developing multistrain PEDV vaccines: Integrating basic concepts and SARS-CoV-2 pan-sarbecovirus strategies
Mario Fragoso-Saavedra, Qiang Liu
Virology (2025) Vol. 604, pp. 110412-110412
Closed Access
Mario Fragoso-Saavedra, Qiang Liu
Virology (2025) Vol. 604, pp. 110412-110412
Closed Access
Role of N-linked glycosylation sites in human ACE2 in SARS-CoV-2 and hCoV-NL63 infection
Sabrina Noettger, Fabian Zech, Rayhane Nchioua, et al.
Journal of Virology (2025)
Open Access
Sabrina Noettger, Fabian Zech, Rayhane Nchioua, et al.
Journal of Virology (2025)
Open Access
Capture of fusion-intermediate conformations of SARS-CoV-2 spike requires receptor binding and cleavage at either the S1/S2 or S2’ site
Sabrina Lusvarghi, Russell Vassell, Brittany Williams, et al.
PLoS Pathogens (2025) Vol. 21, Iss. 4, pp. e1012808-e1012808
Open Access
Sabrina Lusvarghi, Russell Vassell, Brittany Williams, et al.
PLoS Pathogens (2025) Vol. 21, Iss. 4, pp. e1012808-e1012808
Open Access
Exploring TMPRSS2 Drug Target to Combat Influenza and Coronavirus Infection
Krishnaprasad Baby, Megh Pravin Vithalkar, Somasish Ghosh Dastidar, et al.
Scientifica (2025) Vol. 2025, Iss. 1
Open Access
Krishnaprasad Baby, Megh Pravin Vithalkar, Somasish Ghosh Dastidar, et al.
Scientifica (2025) Vol. 2025, Iss. 1
Open Access
SARS-CoV-2 Membrane protein regulates the function of Spike by inhibiting its plasma membrane localization and enzymatic activity of Furin
Qi Xiang, Jie Wu, Yuzheng Zhou, et al.
Microbiological Research (2024) Vol. 282, pp. 127659-127659
Closed Access | Times Cited: 3
Qi Xiang, Jie Wu, Yuzheng Zhou, et al.
Microbiological Research (2024) Vol. 282, pp. 127659-127659
Closed Access | Times Cited: 3
Vero cell-adapted SARS-CoV-2 strain shows increased viral growth through furin-mediated efficient spike cleavage
Shohei Minami, Tomohiro Kotaki, Yusuke Sakai, et al.
Microbiology Spectrum (2024) Vol. 12, Iss. 4
Open Access | Times Cited: 3
Shohei Minami, Tomohiro Kotaki, Yusuke Sakai, et al.
Microbiology Spectrum (2024) Vol. 12, Iss. 4
Open Access | Times Cited: 3
Novel benzimidazole angiotensin receptor blockers with anti-SARS-CoV-2 activity equipotent to that of nirmatrelvir: computational and enzymatic studies
Harry Ridgway, Graham J. Moore, Laura Kate Gadanec, et al.
Expert Opinion on Therapeutic Targets (2024) Vol. 28, Iss. 5, pp. 437-459
Closed Access | Times Cited: 3
Harry Ridgway, Graham J. Moore, Laura Kate Gadanec, et al.
Expert Opinion on Therapeutic Targets (2024) Vol. 28, Iss. 5, pp. 437-459
Closed Access | Times Cited: 3
Myocarditis: causes, mechanisms, and evolving therapies
Tin Kyaw, Grant R. Drummond, Alex Bobik, et al.
Expert Opinion on Therapeutic Targets (2023) Vol. 27, Iss. 3, pp. 225-238
Closed Access | Times Cited: 9
Tin Kyaw, Grant R. Drummond, Alex Bobik, et al.
Expert Opinion on Therapeutic Targets (2023) Vol. 27, Iss. 3, pp. 225-238
Closed Access | Times Cited: 9
The Spike-Stabilizing D614G Mutation Interacts with S1/S2 Cleavage Site Mutations To Promote the Infectious Potential of SARS-CoV-2 Variants
Stacy Gellenoncourt, Nell Saunders, Rémy Robinot, et al.
Journal of Virology (2022) Vol. 96, Iss. 19
Open Access | Times Cited: 14
Stacy Gellenoncourt, Nell Saunders, Rémy Robinot, et al.
Journal of Virology (2022) Vol. 96, Iss. 19
Open Access | Times Cited: 14
Cytotoxicity and effectiveness of archetypal Metal-Organic Frameworks (HKUST-1, UiO-66, MIL-53, MIL-125) against coronaviruses (HCoV-229E and SARS-CoV-2)
Orfeas-Evangelos Plastiras, Peggy Bouquet, Cécile Lecœur, et al.
Microporous and Mesoporous Materials (2023) Vol. 367, pp. 112975-112975
Closed Access | Times Cited: 7
Orfeas-Evangelos Plastiras, Peggy Bouquet, Cécile Lecœur, et al.
Microporous and Mesoporous Materials (2023) Vol. 367, pp. 112975-112975
Closed Access | Times Cited: 7
SP-A binding to the SARS-CoV-2 spike protein using hybrid quantum and classical in silico modeling and molecular pruning by Quantum Approximate Optimization Algorithm (QAOA) Based MaxCut with ZDOCK
Sona Aramyan, Kirk McGregor, Samarth Sandeep, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 12
Sona Aramyan, Kirk McGregor, Samarth Sandeep, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 12
Metalloprotease-Dependent S2′-Activation Promotes Cell–Cell Fusion and Syncytiation of SARS-CoV-2
James V. Harte, Samantha L. Wakerlin, Andrew J. Lindsay, et al.
Viruses (2022) Vol. 14, Iss. 10, pp. 2094-2094
Open Access | Times Cited: 9
James V. Harte, Samantha L. Wakerlin, Andrew J. Lindsay, et al.
Viruses (2022) Vol. 14, Iss. 10, pp. 2094-2094
Open Access | Times Cited: 9
Evaluating Molecular Mechanism of Viral Inhibition of Aerosolized Smart Nano-Enabled Antiviral Therapeutic (SNAT) on SARS-CoV-2-Infected Hamsters
Anais N. Bauer, John F. Williams, Lok R. Pokhrel, et al.
Toxics (2024) Vol. 12, Iss. 7, pp. 495-495
Open Access | Times Cited: 1
Anais N. Bauer, John F. Williams, Lok R. Pokhrel, et al.
Toxics (2024) Vol. 12, Iss. 7, pp. 495-495
Open Access | Times Cited: 1
Cell type-specific adaptation of the SARS-CoV-2 spike
Marc Carrascosa-Sàez, María-Carmen Marqués, Ron Geller, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 2
Marc Carrascosa-Sàez, María-Carmen Marqués, Ron Geller, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 2
SARS-CoV-2 Lysate Stimulation Impairs the Release of Platelet-like Particles and Megakaryopoiesis in the MEG-01 Cell Line
Valentina Lopardo, Francesco Montella, Roberta Maria Esposito, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 5, pp. 4723-4723
Open Access | Times Cited: 2
Valentina Lopardo, Francesco Montella, Roberta Maria Esposito, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 5, pp. 4723-4723
Open Access | Times Cited: 2
Temperature impacts SARS-CoV-2 spike fusogenicity and evolution
Jérémy Dufloo, Rafael Sanjuán
mBio (2024) Vol. 15, Iss. 4
Open Access
Jérémy Dufloo, Rafael Sanjuán
mBio (2024) Vol. 15, Iss. 4
Open Access
A novel approach to designing viral precision vaccines applied to SARS-CoV-2
Khaled Trabelsi, Noureddin Ben Khalaf, Ahmed R. Ramadan, et al.
Frontiers in Cellular and Infection Microbiology (2024) Vol. 14
Open Access
Khaled Trabelsi, Noureddin Ben Khalaf, Ahmed R. Ramadan, et al.
Frontiers in Cellular and Infection Microbiology (2024) Vol. 14
Open Access